Our portfolio company MedAvail listed on the NASDAQ (MDVL) as part of a reverse merger. The company is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Currently deployed in Arizona, California, and Michigan, the company plans to open new care settings in Florida, Illinois and Texas in the future.